dr. fidler on relay trial results in egfr nsclc
Published 4 years ago • 91 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:29
dr. fidler on the flaura trial in egfr-mutant nsclc
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
4:55
practical implications of the relay trial in egfr nsclc
-
1:34
dr. fidler on the utility of dacomitinib in egfr-mutant nsclc
-
1:00
dr. nagawaka discusses findings of the relay trial in egfr nsclc
-
2:20
dr. kris on the relay trial in egfr nsclc
-
2:09
dr. hassan on flaura trial results in egfr-mutant nsclc
-
2:09
dr. ramalingam on flaura trial results in egfr-mutant nsclc
-
1:53
dr. fidler on novel chemotherapy strategies in nonsquamous nsclc
-
6:41
relay: erlotinib with ramucirumab for egfr nsclc
-
2:03
dr. wakelee on rationale to explore osimertinib with concurrent chemotherapy in egfr-mutant nsclc
-
9:36
the flaura trial: practice-changing results for egfr mutation-positive nsclc (bmic-007)
-
7:00
flaura trial: impact of os data in advanced nsclc
-
7:46
egfr and pd-l1 testing in locally advanced nsclc
-
6:51
osimertinib as frontline therapy in egfr-positive nsclc
-
0:43
dr. jackman on overcoming resistance to egfr inhibitors in lung cancer
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
1:59
the flaura trial in egfr nsclc
-
1:36
dr. garassino on increased pfs with ramucirumab combo for nsclc